|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities | |
| Net loss | |
| Adjustments to reconcile net loss to net cash provided by operating activities | |
| Depreciation | |
| Operating lease expenses | |
| Working capital loan interest | |
| Share-based compensation | |
| Changes in operating assets and liabilities | |
| Deferred cost | |
| Contract assets | |
| Trade and other receivables | |
| Amount due from related parties | |
| Contract liabilities | |
| Trade and other payables | |
| Lease liabilities | |
| Income tax payable | |
| Net cash generated from/ (used in) operating activities | |
| Cash flow from investing activities: | |
| Acquisition of property, plant and equipment | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Amount due to shareholders | |
| Repayment of working capital loans | |
| Proceeds from issuance of shares | |
| Net cash (used in)/ generated from financing activities | |
| Effects of changes in foreign exchange of cash | |
| Net (decrease)/ increase in cash and cash equivalents | |
| Cash and cash equivalents at beginning of financial year | |
| Cash and cash equivalents at end of financial year | |
| Supplemental cash flow information | |
| Income taxes paid | |
| Withholding taxes paid | |
| Cash paid for interest | |
| Supplemental disclosure of non-cash flow information | |
| Deferred IPO cost offset with additional paid-in capital |
Loading...
